Unibest
← Back to patent-cliff list

CAS 2353416-91-6

Codes: RIFAB-001

Application context (from source-drug indications)

Helicobacter pylori infectionAmoxicillin/Omeprazole/RifabutinDyspepsiaAmoxicillin/Omeprazole/RifabutinMultidrug-resistant tuberculosisRifabutinMycobacterium avium-intracellulare complex diseaseRifabutinNon-tuberculous mycobacterial infectionRifabutin

Source drugs (routes using this intermediate)

DrugTierExpiry
Amoxicillin/Omeprazole/RifabutinTier C — Watch / trade-
RifabutinTier C — Watch / trade-

Position in synthesis routes (up/downstream chain)

Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.

Amoxicillin/Omeprazole/RifabutinOptimised routesteps: 4total yield: /
RifabutinOptimised routesteps: 4total yield: /

Intermediates available on this site

No listed intermediates for this target yet — send an RFQ directly and it will enter our matching pool.

This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.